Inhibition of PDE ‐4 isoenzyme attenuates frequency and overall contractility of agonist‐evoked ureteral phasic contractions
Pharmacology Research & Perspectives · 2024
DOI: 10.1002/prp2.1175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Iris Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Urology, Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Ureter. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this study was to investigate the functional role of phosphodiesterase enzymes (PDE) in the isolated porcine ureter. Distal ureteral strips were mounted in organ baths and pre‐contracted with 5‐HT (100 μM). Upon generation of stable phasic contractions, PDE‐4 and PDE‐5 inhibitors were added cumulatively to separate tissues. PDE‐4 inhibitors, such as rolipram (10 nM and greater) and roflumilast (100 nM and greater), resulted in significant attenuation of ureteral contractile responses, while a higher concentration of piclamilast (1 μM and greater) was required to induce a significant depressant effect. The attenuation effect by rolipram was abolished by SQ22536 (100 μM). PDE‐5 inhibitors, such as sildenafil and tadalafil, were not nearly as effective and were only able to suppress the 5‐HT‐induced contractions at higher concentrations of 1 μM. Rolipram significantly enhanced the depressant effect of forskolin, while sodium nitroprusside‐induced attenuation of contractile responses remained unchanged in the presence of tadalafil. In summary, our study demonstrates that PDE‐4 inhibitors are effective in attenuating 5‐HT‐induced contractility in porcine distal ureteral tissues, while PDE‐5 inhibitors are less effective. These findings suggest that PDE‐4 inhibitors, such as rolipram, may hold promise as potential therapeutic agents for the treatment of ureteral disorders attributable to increased intra‐ureteral pressure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Urology, Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.
- Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
ORCID-Profile: Iris Lim
Zitieren
APA
Lim, I., Masutani, T., Hashitani, H., Chess-Williams, R., & Sellers, D. (2024). Inhibition of PDE ‐4 isoenzyme attenuates frequency and overall contractility of agonist‐evoked ureteral phasic contractions. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1175
Vancouver
Lim I, Masutani T, Hashitani H, Chess-Williams R, Sellers D. Inhibition of PDE ‐4 isoenzyme attenuates frequency and overall contractility of agonist‐evoked ureteral phasic contractions. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1175
BibTeX
@article{Lim2024,
author = {Lim, Iris and Masutani, Taishi and Hashitani, Hikaru and Chess-Williams, Russ and Sellers, Donna},
title = {Inhibition of PDE ‐4 isoenzyme attenuates frequency and overall contractility of agonist‐evoked ureteral phasic contractions},
journal = {Pharmacology Research & Perspectives},
year = {2024},
doi = {10.1002/prp2.1175}
}
EUVIMED